Digital self-management for fibrotic lung disease
Part of Lungs & breathing clinical trials.
This trial tests whether a digital self-management program (using a smartphone or tablet) helps people with fibrotic interstitial lung disease better manage their symptoms and quality of life. If you have this lung condition and can use a mobile device, this study could offer you extra support at home.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosis of a scarring lung disease called fibrotic interstitial lung disease.
- Own a smartphone or tablet and have an email address.
- Be comfortable using apps or the internet on your device.
- Your lung treatment must be stable (no big changes) for the past 30 days.
- You must be able to understand and speak English.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether using a home monitoring program helps people with pulmonary fibrosis track their condition. It aims to make care easier and catch changes early.
This trial is for people with scarring lung disease (pulmonary fibrosis) in Ireland. It aims to better understand and care for the condition, especially in families. The study will look at medical data and may help improve diagnosis and treatment.
This trial tests whether people with lung disease caused by a rheumatic condition can safely manage their care at home using a smartphone or tablet. It aims to see if home monitoring is as effective as in-person visits for keeping your lungs healthy.
This study tests whether using a home breathing device, combined with artificial intelligence, can help monitor your lung condition between clinic visits. If it works, it might catch changes early and help you stay healthier.
This study tests whether a smartphone app called FORTISKAP helps people stick to their oral medications for lung conditions like interstitial lung disease and pulmonary hypertension. If you join, you'll either use the app or receive usual care, and the goal is to see if the app improves medication routines and outcomes.
This trial tests a smartphone-based program to help people with COPD manage their condition at home. It may help you track symptoms and avoid flare-ups.
Hear when a new Pulmonary Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.